Navigation Links
LaVoie Group Wins Two Mercury Excellence Awards
Date:3/14/2011

SALEM, Mass., March 14, 2011 /PRNewswire/ -- LaVoie Group, the acknowledged leader in life science and pharmaceutical communications, announced today that it has received a Gold Award in the 24th Annual International Mercury Excellence Awards 2010/2011 competition, given annually by MerComm, Inc. LaVoie Group also received Honors for the agency's own website.

The winning Gold award campaign was for Alphatec Spine for creation of their internal communications campaign titled, "Alphatec Spine Brand Book." Alphatec Spine, a growing provider of spinal devices, engaged LaVoie Group following the Company's acquisition of Scient'x, a European spinal products company, to establish brand unification. LaVoie Group, working with designers Gil Fishman Associates, undertook a phased rollout of the Company's new brand through key markets, including a logo redesign and transition, new brand personality, message development, website integration and ultimately, the corporate brand guidelines. The purpose of the program was to establish and maintain a consistent identity, and to promote a positive association of the brand with the newly joined companies.

In addition to receiving the Gold Award, LaVoie Group also received Honors for the re-design of the agency's corporate website, in the category of Self-Promotion: Website. With the new site, www.lavoiegroup.com, LaVoie Group has created an online communication experience that conveys the agency's evolving brand identity, services and core strengths as a leader in life science and pharmaceutical communications.

MerComm, Inc. was founded in 1987 with the principal purpose of advancing the arts and sciences of communications in an international arena. The Mercury Awards are now in their 24th year, receiving over 760 entries from 21 countries in 2010.

Donna L. LaVoie, President and CEO of LaVoie Group commented, "We are thrilled to be recognized for our work with Alphatec Spine and for our own LaVoie Group website. We pride ourselves on creating strategic and impactful public relations, investor relations and branding campaigns, and we're delighted when our work is recognized by an established group like MerComm."

About LaVoie Group

LaVoie Group partners with leading life sciences brands to build their companies, attract capital, and reach key stakeholders through integrated communications programs. We provide senior-level counsel to our clients, create visibility, and develop strategies and implementation tactics for corporate and/or product programs on a global scale.

Our clients are industry leaders in life sciences and pharmaceuticals such as Pfizer Inc., sanofi-aventis, Aegerion Pharmaceuticals, Alphatec Spine, Invida Group, Vertex Pharmaceuticals, and Rockwell Medical.  LaVoie Group is ranked by O'Dwyer's PR Report as one of the leading independent healthcare PR firms in the U.S. and has been honored by the LACP as "Boutique Agency of the Year" in both 2008 and 2009. For more information, please visit http://www.lavoiegroup.com.


'/>"/>
SOURCE LaVoie Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
5. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
6. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
7. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
8. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
11. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):